Dr Chung Shun “CS” Ho, pioneer in mass spectrometry, gives an overview of how the technology and its associated tools have evolved from his 1995 debut. In this episode of Leaders in Conversation with Ronald Lo, General Manager of Roche Diagnostics Hong Kong, Dr Ho recounts how mass spectrometry started from a niche discipline to […]
Dengue cases have surged worldwide during the 2023-24 outbreak season, with the WHO reporting close to a historic high of over five million cases and more than 5000 dengue-related deaths in over 80 countries. [1] Dengue is capable of causing a transfusion-transmitted infection, with several case reports, including a case of severe dengue haemorrhagic fever.
Beyond the bite: why blood transfusion safety matters amidst the global dengue surge Read More »
In this fourth issue of The Value of Diagnostics interview series, Professor Li Xia highlights the specialised role of the Geriatric Psychiatry Department at the Shanghai Mental Health Center in managing cognitive impairment. Unlike neurology departments that focus primarily on cerebrovascular or neurological causes, this department offers “whole-course management” encompassing cognitive function, emotional well-being, and
Why early CSF testing is a game-changer for Alzheimer’s disease in China Read More »
Dr Ain and Dr Farhan, Principal Doctors at Poliklinik Ar Razi in Kuantan, Malaysia, discuss the transformative impact of Point-of-Care Testing (POCT) on their 24-hour primary care facility. Serving a community of approximately 2,000 patients monthly, the clinic manages a split of chronic non-communicable diseases – e.g. diabetes and hypertension – and acute communicable illnesses.
The value of rapid diagnostics: spotlighting POCT in Malaysia’s Poliklinik Ar Razi Read More »
Professor Tawesak Tanwandee, Professor of Gastroenterology at Mahidol University’s Siriraj Hospital, sits down to discuss how the HCV dual assay helps to streamline diagnosis and reduce patient dropout. The HCV dual assay represents a significant shift from conventional screening by providing independent antigen and antibody results from a single test that delivers results in under
In healthcare, the margin between life and death is measured by timely and precise clinical intervention. With diagnostics influencing the vast majority of clinical decisions [1], the laboratory serves as the definitive point of clarity – where clinical certainty calls, the lab answers. To meet surging testing demands, labs are pivoting to total lab automation
The viral infection known as dengue is an increasing public health threat. In 2024, the World Health Organisation received reports of 14.6 million cases of this mosquito-borne virus – a historic high, with infections endemic in more than 100 countries [1]. That number is presumed to be a significant undercount; experts estimate that there are
Why expanding access to accurate dengue tests is a critical need in Asia Read More »
Across the Asia Pacific region, the patient care journey for a dengue infection varies significantly depending on the structure of the local healthcare system [1]. The primary divide stems from whether care is delivered via a centralised model or a community-based model [1]. Delivering appropriate care for patients infected with the dengue virus is increasingly
In Asia, divergent patient care journeys make dengue diagnosis a challenge Read More »
In this episode of Leaders in Conversation, Roche Diagnostics India General Manager Dr Rishubh Gupta speaks with Dr Kunal Sharma, Vice President of Agilus Diagnostics, regarding the transformative role of digital pathology and artificial intelligence in Indian healthcare. Dr Sharma, often referred to as the “cancer guy,” details his leadership in oncology and his efforts
AI as the essential co-pilot for modern digital pathology: Q&A with Dr Kunal Sharma Read More »
When it comes to therapeutics, the core clinical challenge is often distilled down to a critical question: how much drug, and for how long? For too long, the aspiration toward truly personalised medicine has been constrained by the limitations of static, one-size-fits-all dosing and outdated pharmacokinetic (PK) models – a rigid system ill-equipped for advanced
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
